About
Blueprint Medicines discovers and develops targeted small-molecule kinase inhibitors and precision therapies for genomically defined cancers and rare diseases, focusing on oncology and genetic disease indications.
Explore Blueprint Medicines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.